Sudarshan Pharma Industries Limited (BOM:543828)
India · Delayed Price · Currency is INR 28.77
-0.24 (-0.83%)
At close: Jul 15, 2025
BOM:543828 Revenue
In the fiscal year ending March 31, 2025, Sudarshan Pharma Industries had annual revenue of 5.05B INR with 8.95% growth. Sudarshan Pharma Industries had revenue of 2.77B in the half year ending March 31, 2025, with 4.29% growth.
Revenue
5.05B
Revenue Growth
+8.95%
P/S Ratio
1.39
Revenue / Employee
84.17M
Employees
60
Market Cap
7.03B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |